SABS
USDSAB Biotherapeutics Inc. Common Stock
$3.180+0.040 (1.274%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.140
High
$3.330
Low
$3.140
Volume
0.08M
Company Fundamentals
Market Cap
33.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.27M
Exchange
NCM
Currency
USD
52-Week Range
Low $1Current $3.180High $6.6
Related News
GlobeNewswire
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
View more
GlobeNewswire
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.